Multi-institutional, Multi-faceted Integrated Translational Research on Liver Cancer to Develop Prevention and Treatment Strategies and Establish Clinical Guidelines: Basic Preclinical Research, 4P (Personalized, Predictive, Preventive, and Participatory) Research, Epidemiological Research, Behavioral Intervention Research, Meta-analysis, and Economic Evaluation
Funding Agency
Ministry of Health and Welfare
Principal Investigator
Chun-Ying Wu
Project Period
2023/01/01～2023/12/31
Project Title
Multi-institutional, Multi-faceted Integrated Translational Research on Liver Cancer
Funding Agency
Ministry of Health and Welfare
Principal Investigator
Chun-Ying Wu
Project Period
2024/01/01～2024/12/31
Project Title
Multi-institutional Collaborative Cancer Translational Research Project
Funding Agency
Ministry of Health and Welfare
Principal Investigator
Chun-Ying Wu
Project Period
2025/01/01～2025/12/31
National Science and Technology Council
Project Title
Impact of Gut Microbiome on Hepatitis and Liver Cancer Prognosis: Clinical, Big Data, Animal, and Multi-omics Studies (4/4)
Funding Agency
National Science and Technology Council
Principal Investigator
Chun-Ying Wu
Project Period
2023/01/01～2024/04/30
Project Title
Predicting Prognosis of MASLD-related HCC Treatment: Building an Automated System Integrating Clinical Data, Imaging, and Environmental Factors
Funding Agency
National Science and Technology Council
Principal Investigator
Chun-Ying Wu
Project Period
2024/08/01～2027/07/31
Project Title
Risk Assessment of MASLD-related HCC and Interactions Among Immunity, Microbiome, and Metabolome: Big Data, Clinical, Animal, and Multi-omics Analysis – Using Health Big Data and Multimodal Models to Construct Risk Stratification for Predicting MASLD-related HCC Risk (1/3)
Funding Agency
National Science and Technology Council
Principal Investigator
Chun-Ying Wu
Project Period
2025/08/01～2026/07/31
Project Title
Investigating the Interplay between Diabetes and Inflammatory Skin Diseases
Funding Agency
National Science and Technology Council
Principal Investigator
Chen-Yi Wu
Project Period
2025/08/01～2028/07/31
Industry-Academia Collaboration
Project Title
Cell-based Drug Screening Trial Evaluation
Funding Agency
Industry-Academia Collaboration
Principal Investigator
Li-Ling Wu
Project Period
2023/05/01～2024/08/31
Project Title
Mouse Animal Model Drug Trial Evaluation Project
Funding Agency
Industry-Academia Collaboration
Principal Investigator
Li-Ling Wu
Project Period
2023/05/01～2024/01/31
Project Title
Comprehensive HBV Drug Trial Evaluation Project
Funding Agency
Industry-Academia Collaboration
Principal Investigator
Li-Ling Wu
Project Period
2024/04/01～2025/03/31
Project Title
[Handa Biopharmaceutical Co., Ltd.] Evaluating the Efficacy and Safety of Dasatinib in the Treatment of Chronic Phase Chronic Myeloid Leukemia Patients: A Real-World Study Conducted in Taiwan
